University of Maryland Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 253
• Head and Neck Cancer Studies 201
• Multiple Myeloma Research and Treatments 170
• CAR-T cell therapy research 142
• Cancer Immunotherapy and Biomarkers 115
• Hematopoietic Stem Cell Transplantation 108
• Hemoglobinopathies and Related Disorders 94
• Lung Cancer Treatments and Mutations 83
• Prostate Cancer Treatment and Research 64
• Lymphoma Diagnosis and Treatment 61
• Lung Cancer Research Studies 53
• Colorectal Cancer Treatments and Studies 52

Most cited

1. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.

   The New England journal of medicine · 2022 · 1,350 citations · Aaron Rapoport

2. Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.

   The New England journal of medicine · 2025 · 305 citations · Robert Haddad

3. Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.

   The New England journal of medicine · 2023 · 653 citations · Scott Solomon

4. NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 159 citations · Robert Haddad

5. Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.

   The New England journal of medicine · 2025 · 202 citations · Taofeek Owonikoko

6. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.

   Lancet (London, England) · 2022 · 698 citations · Scott Solomon